Frontlight ResearchEarly access
Trial site
Tucson Clinical Research Institute
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes5 trials
- Obesity3 trials
- COPD1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Status
- Completed2 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA1 trial
Running trials
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Recruiting
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Active, not recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity3 recruiting
- Type 2 diabetes3 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026